Gossamer Bio, Inc. (GOSS)
NASDAQ: GOSS · Real-Time Price · USD
1.170
+0.010 (0.86%)
At close: Mar 28, 2025, 4:00 PM
1.209
+0.039 (3.30%)
After-hours: Mar 28, 2025, 6:20 PM EDT
Gossamer Bio Employees
As of December 31, 2024, Gossamer Bio had 145 total employees, including 144 full-time and 1 part-time employees. The number of employees increased by 10 or 7.41% compared to the previous year.
Employees
145
Change (1Y)
10
Growth (1Y)
7.41%
Revenue / Employee
$791,041
Profits / Employee
-$389,848
Market Cap
265.85M
Employees Chart
GOSS News
- 16 days ago - Gossamer Bio Announces Fourth Quarter and Full-Year 2024 Financial Results and Provides Business Update - Business Wire
- 21 days ago - Gossamer Bio Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) - Business Wire
- 6 weeks ago - Gossamer Bio Is A Good Speculative Buy On Seralutinib For PAH And PH-ILD - Seeking Alpha
- 7 weeks ago - Gossamer Bio Presented Clinical and Preclinical Data at the Pulmonary Vascular Research Institute 2025 Annual Congress - Business Wire
- 2 months ago - Gossamer Bio to Present Clinical and Preclinical Data at the Pulmonary Vascular Research Institute 2025 Annual Congress - Business Wire
- 5 months ago - Gossamer Bio Announces Third Quarter 2024 Financial Results and Provides Business Update - Business Wire
- 7 months ago - Gossamer Bio Has One More Shot On Goal And Is Not Likely To Miss - Seeking Alpha
- 7 months ago - Gossamer Bio Announces Data Presentations at the European Respiratory Society Congress 2024 - Business Wire